Genetic counseling in renal masses

scientific article published on 9 November 2008

Genetic counseling in renal masses is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1155/2008/720840
P932PMC publication ID2581790
P698PubMed publication ID19009041
P5875ResearchGate publication ID23473388

P2093author name stringJosé Antonio López-Guerrero
José Rubio-Briones
Antonio Fernández-Serra
Zaida García-Casado
P2860cites workVon Hippel-Lindau disease.Q52372308
Practical and ethical issues with genetic screening.Q53269523
Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.Q55033345
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome.Q55035771
Inactivation of BHD in sporadic renal tumors.Q55036699
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.Q55040958
The Heidelberg classification of renal cell tumours.Q55067278
Benefits of Screening in von Hippel-Lindau Disease – Comparison of Morbidity Associated with Initial Tumours in Affected Parents and ChildrenQ56068020
Original Articles: Kidney Cancer: Hereditary Papillary Renal Cell Carcinoma: Clinical Studies in 10 FamiliesQ56522208
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiencyQ73424214
Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997)Q73930509
Renal cell carcinomaQ78020959
Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndromeQ81425828
Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndromeQ81634316
Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastomaQ83009175
What is ideal genetic counselling? A survey of current international guidelinesQ37057830
Molecular cancer therapy: can our expectation be MET?Q37092832
Regulations and practices of genetic counselling in 38 European countries: the perspective of national representativesQ37163037
Tumorigenic mutations in VHL disrupt folding in vivo by interfering with chaperonin bindingQ40613613
Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancerQ40615261
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studiesQ42828980
Alterations of the Birt-Hogg-Dubé gene (BHD) in sporadic colorectal tumoursQ43074055
Mutations of the Birt-Hogg-Dube (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instabilityQ43074141
Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer.Q43169670
Antiangiogenic therapy for von Hippel-Lindau diseaseQ44776023
Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and JapanQ44846730
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor geneQ44847024
Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissuesQ44895983
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasQ45345804
Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults.Q46417495
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutationsQ46575022
Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patientsQ46943872
Molecular genetic analysis of von Hippel-Lindau diseaseQ47775632
Rapid detection of VHL exon deletions using real-time quantitative PCR.Q49125755
Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor functionQ22009393
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signalingQ24306277
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North AmericaQ24532663
von Hippel-Lindau diseaseQ28180159
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndromeQ28219681
Molecular basis of the VHL hereditary cancer syndromeQ28220414
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stabilityQ29615945
Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program dataQ30666907
Genetic and clinical aspects of familial renal neoplasms.Q33893618
A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothoraxQ33938690
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndromeQ33938826
Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.Q33945016
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerQ34115940
Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parentsQ34146220
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndromeQ34159232
Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.Q34286240
Searching for the hereditary causes of renal-cell carcinomaQ34318015
Hereditary papillary renal cell carcinoma: clinical studies in 10 familiesQ34318458
The changing natural history of renal cell carcinomaQ34391104
Inherited susceptibility to uterine leiomyomas and renal cell cancerQ34514090
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.Q34514928
Benefits of screening in von Hippel-Lindau disease--comparison of morbidity associated with initial tumours in affected parents and childrenQ34520100
Germ-line mutations in nonsyndromic pheochromocytomaQ34523021
The pressure rises: update on the genetics of phaeochromocytomaQ34527649
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancerQ34558244
Studying cancer families to identify kidney cancer genesQ35044182
American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer SusceptibilityQ35105968
Pheochromocytoma: the expanding genetic differential diagnosisQ35203185
Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL geneQ35440133
Molecular genetics of kidney cancerQ35598229
The growing family of hereditary renal cell carcinomaQ35928846
Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeuticsQ36718934
Increased risk of cancer in patients with fumarate hydratase germline mutationQ36930098
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P304page(s)720840
P577publication date2008-11-09
P1433published inAdvances in UrologyQ15756218
P1476titleGenetic counseling in renal masses

Search more.